Ignite Creation Date:
2025-12-24 @ 5:09 PM
Ignite Modification Date:
2025-12-29 @ 12:44 AM
Study NCT ID:
NCT00918450
Status:
WITHDRAWN
Last Update Posted:
2010-02-26
First Post:
2009-05-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study Assessing the Safety and Efficacy of ABT-263 in Subjects With B-cell Chronic Lymphocytic Leukemia (CLL) Who Have Failed at Least One Prior Fludarabine-containing Regimen
Sponsor:
Abbott
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
M10-738
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Sari Enschede, MD
Old Organization:
Abbott Laboratories
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |